Worldwide, consumers prefer generics, says study

Share this article:
Consumers worldwide overwhelmingly prefer medicines that have been around a long time to the latest treatments, and over half prefer generics to branded drugs given the choice, according to a DDB Health survey.

Asked whether they would prefer the latest medicine in its field or one that has been around for awhile, 70% said they'd take the tried-and-true drug over the latest and greatest, and 54% of the 1,800 in 11 countries surveyed said they prefer generics to branded drugs. Of US respondents, 69% said they prefer generics. The finding points to a need to better differentiate newer drugs, said the report. 

"Consumers are not going to be as motivated to take action based solelyon higher-order/emotional end benefits in the pharmaceutical, or evenin the well-being, space," said Maria Tender, DDB director of brandplanning. "Today, more than ever, they will need to see tangiblebenefits ascribed to brands."

Half of consumers and 44% of doctors said they'd do anything to avoid taking medication until absolutely necessary. Behind that, the report said, is distrust of the drug industry, but also a sense that medication represents personal failure or moral compromise. Marketers must give these consumers permission to seek outside help, the report suggested.

“When communicating to patients about medicines, whether those communications are branded or unbranded, patients need to be reassured that they have not been bad,” said the report. “A layer of guilt (if it does exist) needs to be removed before they will take action.”

Of US respondents, 55% said there had been more negative press about pharmas in the past five years, and 47% said they trust drug companies less than they did five years ago. That reflects, in part, democratization of and access to information, the report concluded. On the upside, consumers believe overwhelmingly that the benefits of most medicines outweigh the risks (67%) and that modern medicine has improved society (77%).

Asked to pick between the statements “Taking a medicine every day makes me feel old” and “Taking a medicine every day makes me feel healthy,” consumers in North America, Europe and India favored “healthy” by margins of around 3-2, while more in Mexico, China, Singapore and Australia said drugs make them feel old.  

Two-thirds of consumers said they'd accept a doctor's recommendation to take a drug rather than try to self-manage a condition.

The study, by DDB Health and its Omnicom sibling M/A/R/C Research, surveyed consumers and physicians in the US, Canada, Mexico, Brazil, the UK, France, Germany, China, India, Australia and Singapore.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...